AXSOME THERAPEUTICS, INC. (AXSM) Net margin 2022–2025
AXSOME THERAPEUTICS, INC. (AXSM) net profit margin by fiscal year — reported net income divided by reported revenue.
-28.7%FY2025 · since FY2022: -374.0% → -28.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -28.7% | +45.8 pp |
| FY2024 | -74.5% | +13.9 pp |
| FY2023 | -88.4% | +285.6 pp |
| FY2022 | -374.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AXSM financial trends
AXSM RevenueAXSM Net incomeAXSM Gross profitAXSM Gross marginAXSM Operating incomeAXSM Operating marginAXSM Operating cash flowAXSM Free cash flowAXSM Capital expendituresAXSM Return on equityAXSM Stock buybacksAXSM Dividends paidAXSM Total assetsAXSM Total liabilitiesAXSM Shareholders’ equityAXSM overview →